Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Faehling, M., Schumann, C., Christopoulos, P., Hoffknecht, P., Alt, J., Horn, M., Eisenmann, S., Schlenska-Lange, A., Aries, S. P., Sackmann, S., Schuett, P., Steger, F. and Christoph, D. (2020). Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP). Ann. Oncol., 31. S. S806 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Frost, N., Christopoulos, P., Kauffmann-Guerrero, D., Stratmann, J. A., Riedel, R., Schaefer, M., Alt, J., Guetz, S., Brinkmann, J. and Griesinger, F. (2020). Lorlatinib in pretreated ALK/ROS1-positive non-small cell lung cancer (NSCLC): Results from the German early access program. Ann. Oncol., 31. S. S874 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Sebastian, M., Reck, M., Fischer, R. N., Christoph, D. C. C., Bernhardt, C., von der Heyde, E., Nusch, A., Ludwig, P., Hipper, A., Hanselmann, J., Medinger, T., Binninger, A., Jaenicke, M., Christopoulos, P., Elender, C., Bethge, A., Seese, B., Gauler, T. C. and Waller, C. (2022). First real-world outcome data of SCLC in Germany: Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315). Ann. Oncol., 33 (7). S. S1252 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041

This list was generated on Fri Mar 1 06:17:56 2024 CET.